Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Point Prevalence Study to Evaluate the Prevalence of Antibodies to Selected Porcine Viruses in Patients With Cystic Fibrosis Who Are Receiving Porcine-Derived Pancreatic Enzyme Replacement Therapy: A Harmonized Protocol Across Sponsors

NCT01858519 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT01858519
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01858519 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Point Prevalence Study to Evaluate the Prevalence of Antibodies to Selected Porcine Viruses in Patients With Cystic Fibrosis Who Are Receiving Porcine-Derived Pancreatic Enzyme Replacement Therapy: A Harmonized Protocol Across Sponsors
Lead sponsor
AbbVie
Phase
Observational
Overall status
Completed
Start date
August 31, 2013
Completion date
September 30, 2016
Enrollment
1,310 (actual)
Sites
47

Conditions

As the registry lists them; a condition with its own page is linked.

cystic fibrosis